HemaCell

About:

HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.

Website: http://www.xuejibio.com/

Top Investors: HongShan, Northern Light Venture Capital, CDH Investments, China Construction Bank, Guosen Innovation Equity

Description:

Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.